CLLS CIK: 1627281

Cellectis S.A.

  • France
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
28.5
FY22:
17.4
FY23:
0.02
FY24:
41.5
FY25:
72.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−103
FY22:
−96.2
FY23:
−104
FY24:
−59.6
FY25:
−33.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−96.7
FY22:
−98.6
FY23:
−116
FY24:
−36.8
FY25:
−68.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−125
FY22:
−114
FY23:
−108
FY24:
−36.8
FY25:
−67.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data